U.S. Paper and Forestry Products Stock News

Allison Transmission Holdings (ALSN) closed out FY 2025 with Q4 revenue of US$737 million and basic EPS of US$1.19, alongside net income of US$99 million that sets the tone for how investors read the full year. The company has seen quarterly revenue move from US$824 million in Q3 2024 to US$814 million in Q2 2025, US$693 million in Q3 2025 and then US$737 million in Q4 2025. Basic EPS shifted from US$2.30 to US$2.32, US$1.63 and US$1.19 over the same stretch, giving a clear read on how top...

Navitas Semiconductor (NVTS) has just wrapped up FY 2025 with fourth quarter revenue of US$7.3 million and a basic EPS loss of US$0.14, while trailing 12 month figures show revenue of US$45.9 million and a full year EPS loss of US$0.57. Over the past few quarters, the company has seen revenue move from US$21.7 million with EPS of US$0.10 loss in Q3 2024 to US$10.1 million and EPS of US$0.09 loss in Q3 2025, alongside net income losses ranging from US$18.7 million to US$31.8 million in recent...

WisdomTree snapshot WisdomTree (WT) has drawn fresh attention after a stretch of strong returns across multiple timeframes, with the stock showing gains over the past week, month, past 3 months and year to date. That recent performance sits alongside reported annual revenue of US$493.753m and net income of US$109.133m, giving investors a reference point for assessing how the exchange traded fund sponsor and asset manager compares with its share price. See our latest analysis for...

In February 2026, Sensata Technologies Holding plc reported fourth-quarter 2025 sales of US$917.9 million and net income of US$63.2 million, alongside full-year 2025 sales of US$3.70 billion and net income of US$31.3 million. Despite lower full-year revenue and earnings versus the prior year, the company delivered a sharp quarterly profit rebound and reorganized into three segments that each achieved organic revenue growth and margin expansion. Now we will examine how Sensata’s stronger...

What triggered the latest interest in Nucor stock Nucor (NUE) has drawn fresh attention after its Board approved a new US$4.0b share repurchase program, reaffirmed a regular US$0.56 quarterly dividend, and appointed Jack Sullivan as Chief Financial Officer. See our latest analysis for Nucor. Nucor's latest US$4.0b buyback authorization and continued dividend track record come after a mixed stretch for the share price, with a 7 day share price return of 4.91% decline, a 90 day share price...

Teekay Tankers (TNK) is back in focus after its fourth quarter 2025 earnings, where net income and earnings per share were higher year over year, alongside ongoing fleet renewal and a continued quarterly dividend. See our latest analysis for Teekay Tankers. The latest earnings news comes after a strong run for the shares, with a 30 day share price return of 21.68% and a year to date share price return of 45.18%. The 1 year total shareholder return of 96.06%, together with a very large 5 year...

Merit Medical Systems (MMSI) closed FY 2025 with fourth quarter revenue of US$393.9 million and basic EPS of US$0.64, supported by trailing twelve month revenue of US$1.5 billion and EPS of US$2.17 that frame the full year picture. Over the past six reported quarters, the company has seen quarterly revenue move from US$339.8 million in Q3 2024 to US$393.9 million in Q4 2025, while quarterly basic EPS ranged between US$0.47 and US$0.64 across that stretch. With trailing net profit margin at...

Institutional buying and late stage trials draw attention to Kodiak Sciences Baker Bros. Advisors recently expanded its position in Kodiak Sciences (KOD) by 2,608,696 shares, an estimated US$53.42 million purchase that is putting fresh focus on the biotech as its retinal disease programs advance. See our latest analysis for Kodiak Sciences. Kodiak Sciences’ share price has been volatile, with a 12.37% 7 day share price return and 23.08% 90 day share price return. Its 1 year total shareholder...

If you are wondering whether Newell Brands at US$4.56 is a bargain or a value trap, you are not alone. This article is here to unpack what the current share price might be implying. The stock has had mixed returns, with a 3.2% decline over the last 7 days, a 4.6% gain over the last 30 days, a 22.6% gain year to date, and a 24.3% decline over the past year. These moves can change how investors think about both upside potential and risk. Recent company updates and ongoing restructuring efforts...

AGCO recently showcased its Fendt, Massey Ferguson and PTx brands at the 2026 Commodity Classic, highlighting new precision agriculture equipment, retrofit autonomy solutions and advanced digital platforms, while AGCO Power’s Core80 engine was named Diesel Engine of the Year 2026 for its off‑highway powertrain innovation. Together with the completion of share repurchases totaling US$515,000,000 across two programs, these product and technology milestones underline AGCO’s focus on higher‑tech...

If you are wondering whether Pulse Biosciences at around US$19.21 is priced fairly or if the market is getting ahead of itself, this article walks through what the numbers indicate about its value. The share price has had a mixed run, with a 24.5% decline over the last week, a 34.1% gain over the last month, a 43.5% gain year to date, a 0.7% decline over the last year, a very large 3 year return of around 7x, and a 30.8% decline over five years. Recent news coverage around Pulse Biosciences...

If you are wondering whether Ubiquiti's current share price reflects its true worth, this article walks through the key numbers so you can judge the value story for yourself. Ubiquiti's share price recently closed at US$755.43, with returns of 6.8% over 7 days, 37.6% over 30 days, 33.4% year to date, 123.4% over 1 year, 192.3% over 3 years, and 143.0% over 5 years. These figures raise fair questions about what is already priced in and how risk is being viewed. Recent coverage of Ubiquiti has...

Event driven snapshot of LeMaitre Vascular LeMaitre Vascular (LMAT) has drawn investor attention after recent share price moves, with the stock last closing at $91.38, prompting a closer look at how its fundamentals line up with current market pricing. See our latest analysis for LeMaitre Vascular. At $91.38, LeMaitre Vascular’s recent momentum has been relatively firm, with a 30 day share price return of 7.15% and a year to date share price return of 13.98%. This comes even though the 1 year...

Fidelity National Financial, Inc. recently reported fourth-quarter 2025 results showing revenue of US$4,051 million but a net loss of US$117 million, while also declaring a US$0.52 per-share quarterly dividend payable on March 31, 2026, to shareholders of record on March 17, 2026. Despite weaker bottom-line results and ongoing share repurchases totaling US$251.19 million for 4,427,671 shares under its current program, the company is emphasizing strong commercial activity and industry-leading...

The AES Corporation recently announced it has entered 20‑year Power Purchase Agreements with Google to develop and own co‑located energy generation for a new data center in Wilbarger County, Texas, including securing land, grid interconnection, and building shared electricity infrastructure. This long-duration partnership deepens AES’s role as an energy provider to hyperscale data centers, highlighting its capabilities in delivering tailored, on-site power and long-term energy management...

Zeta Global Holdings (ZETA) closed FY 2025 with Q4 revenue of US$394.6 million and basic EPS of US$0.03, alongside net income of US$6.5 million, setting a clear marker after a year that started in the red. Over the past four quarters, the company reported revenue increasing from US$314.7 million in Q4 2024 to US$394.6 million in Q4 2025, while basic EPS moved from US$0.07 to US$0.03. Trailing twelve month EPS stood at a loss of US$0.13, so the latest quarterly profit comes against a year that...

If you are wondering whether Infinity Natural Resources is priced attractively right now, you are not alone. This article focuses on what the current share price might mean for value-driven investors. Over the shorter term, the stock has seen a 1.5% decline over the last 7 days, a 4.3% return over 30 days and a 9.2% return year to date, while the 1-year return sits at a 14.2% decline from the previous level. These mixed returns sit against a backdrop where investors are paying closer...

Why Verisk Analytics is on investors’ radar today Verisk Analytics (VRSK) operates in the insurance data and analytics space, and its recent share performance has been mixed, with gains over the past 3 years but weaker returns over the past year. See our latest analysis for Verisk Analytics. At around US$195.82, Verisk’s share price has seen a 6.38% 7-day share price return after a weaker 30-day share price return of a 10.89% decline and a 1-year total shareholder return of a 31.55% decline,...

If you are wondering whether M/I Homes is still good value after a strong multi year run, this article walks through how its current share price stacks up against several valuation measures. The stock closed at US$140.40 recently, with returns of 4.8% over 30 days, 9.8% year to date and 17.9% over 1 year. The 3 year return sits at a very large 138.7%, and the 5 year return at 180.7%. Recent coverage of M/I Homes has focused on its position within the U.S. homebuilding sector and how...

What stands out about HCA Healthcare right now HCA Healthcare (HCA) has drawn investor attention after recent performance data, with the stock showing a 1 day return of 2.67%, a month return of 14.44%, and a past 3 months return of 5.01%. See our latest analysis for HCA Healthcare. That recent 14.4% 1 month share price return, on top of a 14.9% year to date share price gain, sits alongside a 1 year total shareholder return of 70.2%. This suggests strong momentum rather than a short lived...

Recent commentary around United States Lime & Minerals (USLM) has focused on its strong earnings, solid revenue and profit growth, and cautious capital allocation, particularly its emphasis on maintaining a strong balance sheet and returning cash to shareholders. See our latest analysis for United States Lime & Minerals. At a share price of $112.85, United States Lime & Minerals has seen a 6.7% year to date share price decline and a 12.2% 1 month share price pullback. However, its 1 year...

Spotify Technology (NYSE:SPOT) has launched its Prompted Playlist feature in beta, using AI to build playlists from natural language prompts. The beta is rolling out across multiple countries, giving users early access to a new way of personalizing their listening experience. This feature draws on Spotify's existing data and AI tools to help users move from broad mood or activity descriptions to tailored playlists. For investors tracking NYSE:SPOT, the Prompted Playlist beta lands at a time...

If you are wondering whether Enova International's current share price fairly reflects its underlying worth, you are not alone. That is exactly what this valuation focused review is set up to unpack for you. The stock last closed at US$144.43, with returns of 41.0% over 1 year, 190.1% over 3 years and 351.3% over 5 years, even as the share price has seen a 3.1% decline over 7 days, an 8.9% decline over 30 days and a 10.8% decline year to date. Recent attention on Enova International has been...

Over the past few years, Quanex Building Products has experienced a significant drop in operating margin, earnings per share, and return on invested capital despite continuing to grow its revenue base. This combination of rising costs and weaker profitability on a per‑share and invested‑capital basis points to mounting operational pressures and fewer attractive growth opportunities within the business. Next, we’ll examine how this sustained margin deterioration challenges Quanex’s earlier...